RxDoctor Payments Data

Gregory Tom

Corneal and Contact Management · San Ramon, CANPI 1124245568

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $13,195 of the $15,936 with a category attached, or 82.8%. Lumenis BE Inc accounts for 68.4% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $10,873, more than ten times the $63 reported in 2020. Among corneal and contact management clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,936in general payments, 2019–2025

Across 72 payments — averaging $221.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lumenis BE Inc$11K
  • Coopervision Inc.$3K
  • Johnson & Johnson Vision Care, Inc.$1K
  • Optos, Inc.$347
  • Alcon$53
  • Sight Sciences, Inc.$43
  • plus $77 from 3 others

What the payments were for

  • Speaking & faculty fees$2,50016%
  • Food & beverage$13,19583%
  • Entertainment$2422%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,936 in reported general payments places this provider in the 90th percentile of 140 corneal and contact management providers in California.

See all corneal and contact management providers in California

Medicare billing

Part B allowed, 2024
$69,955
Medicare patients
135
Services billed
799

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost73$917
Timolol Maleate23$289
Doxycycline Hyclate14$234
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha18$181
Brimonidine Tartrate12$70

Paid to pharmacies, not to this prescriber.

Other corneal and contact management in San Ramon

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →